サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1513909

足白癬（水虫）治療の世界市場

Tinea Pedis (Athlete's Foot) Treatment

出版日
ページ情報
英文 284 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
足白癬（水虫）治療の世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 284 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

足白癬（水虫）治療の世界市場は2030年までに13億米ドルに達する

2023年に10億米ドルと推定される足白癬（水虫）治療の世界市場は、分析期間2023-2030年にCAGR 3.1%で成長し、2030年には13億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである局所投与は、CAGR 3.3%を記録し、分析期間終了時には7億5,630万米ドルに達すると予測されます。経口投与セグメントの成長率は、分析期間中CAGR 2.8％と推定されます。

米国市場は2億7,470万米ドルと推定、中国はCAGR 5.2％で成長予測

米国の足白癬（水虫）治療市場は、2023年に2億7,470万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに2億4,840万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは5.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.7%と2.6%と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

足白癬（水虫）治療-主要動向と促進要因

足白癬（水虫）は一般的な真菌感染症であり、特に暖かく湿気の多い環境で足の皮膚を侵します。この感染症は、そのような環境で繁殖する真菌である皮膚糸状菌によって引き起こされ、足の指の間や足の裏のかゆみ、ほてり、ひび割れなどの症状を引き起こします。場合によっては、水ぶくれができたり、皮がむけたりすることもあります。水虫は感染力が強く、感染者との直接的な接触や、ロッカールームの床、シャワー、プールエリアなどの汚染された表面に触れることで感染が広がります。治療には一般的に抗真菌薬が使用され、感染の重症度に応じて外用または内服されます。軽症の場合は、市販の抗真菌クリーム、パウダー、スプレーが一般的に使用されるが、重症の場合や感染が持続する場合は、処方箋が必要な場合もあります。

足白癬の治療法の進歩により、様々な効果的な選択肢があります。クロトリマゾール、ミコナゾール、テルビナフィンのような局所抗真菌治療は、広く利用可能で、多くの患者に有効です。これらの治療は真菌の細胞膜を破壊することで真菌を死滅させ、それ以上の増殖を防ぐ。より重症の感染症や広範囲の感染症には、フルコナゾールやイトラコナゾールなどの経口抗真菌薬が処方されることが多いです。これらの全身的治療は、外用療法だけでは効果がない患者に特に有効です。さらに、抗真菌剤と抗炎症成分を含む併用療法が開発されたことで、感染とかゆみや炎症などの関連症状の両方に対処できるようになり、治療成績が向上しています。足を乾燥させない、通気性の良い靴を履く、身の回りのものを共有しないなどの予防策も、水虫の管理・予防には重要です。

足白癬治療市場の成長は、いくつかの要因によってもたらされます。真菌感染とその健康への影響に対する意識の高まりにより、効果的な治療に対する需要が高まっています。ドラッグ製剤とドラッグデリバリー・システムの技術的進歩により、より効率的で便利な治療選択肢が生まれ、患者のコンプライアンスと治療成績が向上しました。また、スポーツや屋外活動への参加の増加など、水虫の蔓延を助長する生活習慣要因の流行も市場参入企業の成長を後押ししています。さらに、ヘルスケアのインフラが拡大し、市販薬が利用できるようになったことで、より多くの人々が治療を受けやすくなっています。新たな抗真菌剤の開発や併用療法の研究が進むことで、治療の幅が広がり続けています。また、教育キャンペーンやプロモーションを含む製薬会社のマーケティング戦略も消費者の認知度を高め、これらの治療法の普及を後押ししています。こうした動向が進化を続ける中、足白癬治療市場は、継続的な技術革新と個人衛生および予防医療への関心の高まりに支えられ、持続的な成長が見込まれます。

調査対象企業の例（注目の43社）

  • Alva-Amco Pharmacal Companies, Inc.
  • Cipla Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • ProFoot, Inc.
  • Qilu Pharmaceutical Co., Ltd.
  • Taisho Pharmaceutical Co., Ltd.
  • Taro Pharmaceutical Industries Ltd.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-6540

Global Tinea Pedis (Athlete's Foot) Treatment Market to Reach US$1.3 Billion by 2030

The global market for Tinea Pedis (Athlete's Foot) Treatment estimated at US$1.0 Billion in the year 2023, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2023-2030. Topical Administration, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$756.3 Million by the end of the analysis period. Growth in the Oral Administration segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$274.7 Million While China is Forecast to Grow at 5.2% CAGR

The Tinea Pedis (Athlete's Foot) Treatment market in the U.S. is estimated at US$274.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$248.4 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Tinea Pedis (Athlete's Foot) Treatment - Key Trends and Drivers

Tinea pedis, or athlete's foot, is a common fungal infection that affects the skin on the feet, particularly in warm and moist environments. This infection is caused by dermatophytes, fungi that thrive in such conditions, leading to symptoms like itching, burning, and cracked skin between the toes or on the soles of the feet. In some cases, the infection can cause blistering or peeling skin. Athlete's foot is highly contagious, spreading through direct contact with an infected individual or by touching contaminated surfaces, such as locker room floors, showers, and pool areas. Treatment typically involves antifungal medications, which can be applied topically or taken orally, depending on the severity of the infection. For mild cases, over-the-counter antifungal creams, powders, and sprays are commonly used, while more severe or persistent infections may require prescription-strength medications.

Advancements in the treatment of tinea pedis have led to a variety of effective options. Topical antifungal treatments like clotrimazole, miconazole, and terbinafine are widely accessible and effective for many patients. These treatments work by disrupting the cell membranes of the fungi, thereby killing them and preventing further growth. For more severe or widespread infections, oral antifungal medications such as fluconazole and itraconazole are often prescribed. These systemic treatments are particularly beneficial for patients who do not respond to topical therapies alone. Additionally, the development of combination therapies that include antifungal agents and anti-inflammatory ingredients has improved treatment outcomes by addressing both the infection and associated symptoms like itching and inflammation. Preventive measures, including keeping feet dry, wearing breathable footwear, and avoiding the sharing of personal items, are also important in managing and preventing athlete's foot.

The growth in the tinea pedis treatment market is driven by several factors. Increased awareness of fungal infections and their health impacts has led to a higher demand for effective treatments. Technological advancements in drug formulation and delivery systems have resulted in more efficient and convenient treatment options, improving patient compliance and outcomes. The rising prevalence of lifestyle factors that contribute to the spread of athlete's foot such as increased participation in sports and outdoor activities also fuels market growth. Additionally, the expansion of healthcare infrastructure and the availability of over-the-counter medications have made treatments more accessible to a wider population. The development of new antifungal agents and ongoing research into combination therapies continue to broaden the treatment landscape. Marketing strategies by pharmaceutical companies, including educational campaigns and promotions, have also heightened consumer awareness and driven the adoption of these treatments. As these trends continue to evolve, the tinea pedis treatment market is expected to see sustained growth, supported by ongoing innovations and an increasing focus on personal hygiene and preventive healthcare.

Select Competitors (Total 43 Featured) -

  • Alva-Amco Pharmacal Companies, Inc.
  • Cipla Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • ProFoot, Inc.
  • Qilu Pharmaceutical Co., Ltd.
  • Taisho Pharmaceutical Co., Ltd.
  • Taro Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Tinea Pedis (Athlete's Foot) Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Awareness of Fungal Infections Expands Addressable Market Opportunity
    • Innovations in Drug Delivery Systems Strengthen Business Case for New Therapies
    • Rising Participation in Sports and Outdoor Activities Spurs Demand for Treatments
    • Enhanced Accessibility of Over-the-Counter Medications Drives Market Growth
    • Development of Combination Therapies Improves Treatment Outcomes
    • Expansion of Healthcare Infrastructure Accelerates Demand for Antifungal Products
    • Increasing Focus on Personal Hygiene Sustains Market Growth
    • Emergence of New Antifungal Agents Boosts Innovation
    • Integration of Preventive Measures and Treatment Products Expands Market Reach
    • Rising Consumer Preference for Natural and Organic Products Generates New Opportunities
    • Influence of Digital Health Platforms on Treatment Accessibility
    • Increasing Incidence of Drug-Resistant Fungal Strains Creates Challenges
    • Role of Online Pharmacies and E-Commerce Platforms in Expanding Market Access
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Tinea Pedis (Athlete's Foot) Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Drug Stores by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Drug Stores by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Drug Stores by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Tinea Pedis (Athlete's Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • JAPAN
    • Tinea Pedis (Athlete's Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • CHINA
    • Tinea Pedis (Athlete's Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • EUROPE
    • Tinea Pedis (Athlete's Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • FRANCE
    • Tinea Pedis (Athlete's Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • GERMANY
    • Tinea Pedis (Athlete's Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Tinea Pedis (Athlete's Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Tinea Pedis (Athlete's Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Tinea Pedis (Athlete's Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • INDIA
    • Tinea Pedis (Athlete's Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Tinea Pedis (Athlete's Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Tinea Pedis (Athlete's Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030
  • AFRICA
    • Tinea Pedis (Athlete's Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Tinea Pedis (Athlete's Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2014, 2024 & 2030

IV. COMPETITION